The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials
Open accessAbstract
Background: Excess body weight and sub-optimal lifestyle are modifiable causes of breast cancer and other diseases. There is little evidence that behaviour change is possible within screening programmes and whether this is influenced by prior knowledge of disease risk. We determined whether breast cancer risk influences uptake, retention and efficacy of a weight control programme in the UK National Health Service Breast Screening Programme, and whether additional cardiovascular disease and type 2 diabetes risk information improves uptake and retention further. Method: Overweight/obese women in the UK National Health Service Breast Screening Programme identified at high, moderately increased, average and low-risk of breast cancer were randomised to receive individualised breast cancer risk information (breast cancer prevention programme), or individualised breast cancer, cardiovascular disease (QRISK2) and type 2 diabetes (QDiabetes, HbA1c) information (multiple disease prevention programme). Personalised breast cancer risk feedback was given before randomisation in Study-1, and after randomisation in Study-2. Results: Recruitment was 9% (126/1356) in Study-1 and 7% (52/738) in Study-2. With respect to breast cancer risk, odds ratio of uptake for high/moderately increased vs low risk women was 1.99 (95% CI 1.24–3.17, P = 0.004) in Study-1 and 3.58 (95% CI 1.59–8.07, P = 0.002) in Study-2. Odds ratio of retention for high/moderately increased -risk vs. low risk women was 2.98 (95% CI 1.05–8.47, P = 0.041) in Study-1 and 3.88 (95% CI 1.07–14.04, P = 0.039) in Study-2. Weight loss of ≥5% at 12 months was achieved by 63% high/moderate vs. 43% low-risk women in Study-1 (P = 0.083) and 39% vs. 8% in Study-2 (P = 0.008). Uptake, retention and weight loss were equivalent in both the breast cancer prevention programme and the multiple disease prevention programme in both studies. Conclusions: Women who are informed that they are at increased breast cancer risk were significantly more likely to join and remain in the programmes and consequently lose more weight across both studies. High risk women are more likely engage in a lifetyle prevention programme and also have the greatest potential benefit fom risk reduction strategies. Trial registration: ISRCTN91372184 Registered 28 September 2014.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The local interaction of adipose tissue and tumor cell microenvironments may also be important in the promotion of cancer.1761,1762”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1762]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“higher BMI is associated with increased systemic levels of endogenous insulin, insulin-like growth factors, adipokines, inflammatory cytokines, and angiogenic factors that have potential procancerous effects.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1762]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Sick individuals and sick populations
Rose, G. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.427 · Cited by 3,736
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Gakidou, E., Afshin, A., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Aboyans, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32366-8 · Cited by 2,406 · cited 9×
“There is limited information about the acceptability, potential benefits or harms of a multiple disease prevention programme which provides risk information across a number of diseases (breast cancer, CVD and diabetes) [14].”
BackgroundInfluentialParkin, D. M., Boyd, L., & Walker, L. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.489 · Cited by 663
Multiple risk factor interventions for primary prevention of coronary heart disease
Ebrahim, S., Taylor, F., Ward, K., Beswick, A., Burke, M., & Davey Smith, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001561.pub3 · Cited by 546 · cited 1×
“Women were advised weight loss of ≥5% and adherence to PA and alcohol recommendations could lead to significant reductions in risk of BC (25%) [23, 24], T2D (60%) [25] and CVD (30%) [26].”
Hollands, G. J., French, D. P., Griffin, S. J., Prevost, A. T., Sutton, S., King, S., & Marteau, T. M. (2016) · BMJ · doi:10.1136/bmj.i1102 · Cited by 483
Self-citationCooke, R., & Sheeran, P. (2004) · British Journal of Social Psychology · doi:10.1348/0144666041501688 · Cited by 446
Harvie, M., Wright, C., Pegington, M., McMullan, D., Mitchell, E., Martin, B., Cutler, R. G., Evans, G., Whiteside, S., Maudsley, S., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000792 · Cited by 431
Self-citationMaas, P., Barrdahl, M., Joshi, A. D., Auer, P. L., Gaudet, M. M., Milne, R. L., Schumacher, F. R., Anderson, W. F., Check, D., Chattopadhyay, S., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1025 · Cited by 373
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Pashayan, N., Antoniou, A. C., Ivanus, U., Esserman, L. J., Easton, D. F., French, D., Sroczynski, G., Hall, P., Cuzick, J., Evans, D. G., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0388-9 · Cited by 438
Self-citationDoes Losing Weight Lower the Risk of Cancer: A Systematic Review and Meta-analysis
Tzenios, N., Tazanios, M., Poh, O. B. J., & Chahine, M. (2022) · Preprints.org · doi:10.20944/preprints202211.0454.v1 · Cited by 162
French, D., Astley, S., Brentnall, A. R., Cuzick, J. M., Dobrashian, R., Duffy, S. W., Gorman, L. S., Harkness, E. F., Harrison, F., Harvie, M., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07054-2 · Cited by 87
Self-citationRainey, L., van der Waal, D., & Broeders, M. J. M. (2020) · BMC Cancer · doi:10.1186/s12885-020-07464-2 · Cited by 52
“These women consequently lost more weight than women who were not at increased risk [23].”
BackgroundResult
Metadata
- Authors
- Harvie, M., Pegington, M., French, D., Cooper, G., McDiarmid, S., Howell, A., Donnelly, L., Ruane, H., Sellers, K., Foden, P., & Evans, D. G.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- Manchester University NHS Foundation Trust (GB)
- Corresponding author
- Harvie, Michelle
- ORCID
- Venue
- BMC Cancer
- Published
- 2019-12
- Volume
- 19
- Issue
- 1
- Pages
- 1089-1089
- ISSN
- 1471-2407 (ISSN-L)
- PMC
- PMC6892016
- OpenAlex
- W2994434911
- Cited by
- 34
- References
- 31
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 6 · 2022: 13 · 2021: 5 · 2020: 6
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3 d)
- Locations
- BMC Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Prevent Breast Cancer (GA15-007)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
- Keywords
- slimming program, obesity, overweight women, cardiovascular risk, type 2 diabetes risk, QRISK2, HbA1c, breast cancer prevention, feasibility trial, weight loss efficacy, lifestyle modification, National Health Service
- MeSH terms
- Aged, Breast Neoplasms, Cardiovascular Diseases, Diabetes Mellitus, Type 2, England, Feasibility Studies, Female, Humans, Health Knowledge, Attitudes, Practice, Middle Aged, Patient Acceptance of Health Care, Weight Loss, Overweight, Early Detection of Cancer, Weight Reduction Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials. https://app.cochat.ai/papers/10.1186/s12885-019-6279-8
- The paper
- Harvie, M., Pegington, M., French, D., Cooper, G., McDiarmid, S., Howell, A., Donnelly, L., Ruane, H., Sellers, K., Foden, P., & Evans, D. G. (2019). Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials. BMC Cancer. https://doi.org/10.1186/s12885-019-6279-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.